Monoclonal antibodies-target over expressed cell surface receptors
chimeric human mouse MAB, rituximsb
humanized mouse MAB, bevacizumab
human MAB, denusomab
small molecule inhibitors-target intracellular molecules
tyrosine kinase inhibitor, imatinib
proteasome inhibitor. bortezomib
cyclin dependent kinase inhibitor, palbociclib
receptor fusion proteins
-cept
TNF alpha antagonist, etanercept
interleukin receptor modulator (-kin) agonists and antagonist of interleukin receptors
IL-2 agonist/analog, aldesleukin
interleukin receptor antagonist, anakinra